# Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer

> **NCT00213980** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 68 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Zoledronate

## Key facts

- **NCT ID:** NCT00213980
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2019-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213980, "Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00213980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*